Delivery Order SPE2DB24D9238-SPE2DB25FDQZE
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract is for the supply of BOTOX 100 unit vials to support the recurring medical needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and carries no set-aside designation. This award represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,937.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, effective August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's...
- The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a single-award transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $53,070.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 100-unit vials of Botox and is not set aside. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,845.92 contract is for the supply of BOTOX 100 unit vials, with a period of performance through August 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999. The...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,768.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of the pharmaceutical product Botox, with a performance period through June 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $2,587.40, was awarded on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract carries no set-aside designation, and performance will take place at the vendor's Park Ridge facility. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order is for the provision of 100-unit vials of Botox, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical...
- SPE2DB24D9238Indefinite Delivery Contract
- SPE2DB24D9238-SPE2DB25FDQZEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,101.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. This firm fixed-price delivery order is scheduled for ultimate completion by September 11, 2025, and was awarded on August 20, 2025, with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle that authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple contracts with the DLA covering an extensive portfolio of medications and medical consumables, including specialty pharmaceuticals, biologics, and injectable products. The company's core competency in distributing branded and generic prescription drugs, over-the-counter medications, and specialized medical products to military healthcare systems positions it as a reliable vendor for the government's ongoing pharmaceutical supply requirements across Department of Defense facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 8/20/25 |